medigraphic.com
Instituto Nacional de Salud Pública

2013, Number 3

<< Back Next >>

salud publica mex 2013; 55 (3)

Development and implementation of guidelines for quality assurance in breast cancer screening: The European experience

von Karsa L, Arrossi S

Language: English
References: 26
Page: 318-328
PDF size: 429.53 Kb.


ABSTRACT

In Europe, as in many other regions of the world, breast cancer is a major cause of suffering and death. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. Comprehensive quality assurance guidelines for breast cancer screening based on mammography have been developed in the Europe Against Cancer programme with the aim of maximising screening benefits while minimising adverse effects, such as unnecessary examination or treatment resulting from false-positive screening tests. The present report provides an overview of the European experience in developing and implementing quality assurance guidelines for breast cancer screening. It highlights implications relevant to those regions of the world in which the burden of breast cancer in the coming years will make population-based screening an option for cancer control.


REFERENCES

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010.

  2. Boyle P, Levin B (eds.). World Cancer Report. Acting for Prevention - Screening for Breast Cancer, in World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer, 2008: 296-301.

  3. Chen HH, Duffy SW, Tabar L, Day NE. Markov chain models for progression of breast cancer Part I: tumour attributes and the preclinical screen-detectable phase. J Epidemiol Biostat 1997; 2 (1): 9-23.

  4. Fletcher SW, Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med 2003;348(17):1672-1680.

  5. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 1996;66(4): 413-419.

  6. IARC. IARC handbooks of cancer prevention, Breast cancer screening. Lyon, France: International Agency for Research on Cancer, 2002, vol. 7.

  7. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94(19):1445-1457.

  8. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006; 12 Suppl 1:S3-S15.

  9. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15(1): 45-51.

  10. Paci E, the EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012;19 Suppl. 1: 5-13.

  11. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edition, summary document. Ann Oncol 2008;19(4): 614-622.

  12. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (eds.). European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: European Commission, Office for Official Publications of the European Communities, 2006.

  13. von Karsa L. Mammographie Screening - umfassendes, populationsbezogenes Qualitätsmanagement ist hier gefragt! Mammography screening – comprehensive, population-based quality assurance is required! Z Allgemeinmed 1995; 71:1863-1867.

  14. von Karsa L, Lignini TA, Patnick J, Lambert R, Sauvaget C. The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol 2010; 24: 4: 381-396.

  15. Yankaskas BC, Klabunde CN, Ancelle-Park R, Renner G, Wang H, Fracheboud J et al. International comparison of performance measures for screening mammography: can it be done? J Med Screen 2004; 11(4):187-193.

  16. US Food and Drug Administration. Radiation emitting products. Mammography Quality Standards Act and Program. 2013. [Accessed 14 April 2013]. Available from: http://www.fda.gov/Radiation-EmittingProducts/ MammographyQualityStandardsActandProgram.

  17. Kirkpatrick A, Törnberg S, Thijssen M (eds.). European guidelines for quality assurance in mammography screening. Luxembourg: European Commission, Office for Official Publications of the European Communities, 1993.

  18. de Waard F, Kirkpatrick A, Perry NM, Törnberg S, Tubiana M, Wolf C. Breast cancer screening in the framework of the Europe against Cancer programme. Eur J Cancer Prev 1994; 3 Suppl. 1: 3-5.

  19. Segnan N, Patnick J, von Karsa L (eds.). European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Luxembourg: European Commission, Publications Office of the European Union, 2010.

  20. von Karsa L, the European Colorectal Cancer Screening Guidelines Working Group. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication. Endoscopy 2013;45(1):51-59.

  21. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M et al. Cancer screening in the European Union - Report on the implementation of the Council Recommendation on cancer screening, First Report. Luxembourg: European Commission, 2008.

  22. von Karsa L, Suonio E, Lignini T, Ducarroz S, Anttila A (eds.). Current Status and Future Directions of Breast and Cervical Cancer Prevention and Early Detection in Belarus. Cancer Control Assessment and Advice Requested by the Belarus Ministry of Health. Report of Expert Mission to Minsk, Belarus, 15-18 February 2011. Lyon, France: IARC/WHO, 2012. [Accessed 14 April 2013]. Available from http://www.iarc.fr/en/publications/ pdfs-online/wrk/wrk6/Belarus_Report.pdf

  23. Lynge E, Törnberg S, von Karsa L, Segnan N, van Delden JJ. Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer 2012; 48(5): 743-748.

  24. Council of the European Union. Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union no. L 327 2003: 34-38.

  25. Commission of the European Communities. Report from the Commission to the Council, the European Parliament, the European Economic and Social committee and the Committee of the Regions - Implementation of the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC) Brussels, COM (2008) 882 final. Brussels: Commission of the European Communities, 2008.

  26. Council of the European Union. Council Conclusions on reducing the burden of cancer. 2876th Employment, Social Policy, Health and Consumer Affairs Council meeting, Luxembourg, 10 June 2008. Press Office of the Council of the European Union, Brussels, Belgium. [Accessed 14 April 2013]. Available from: http://consilium.europa.eu/Newsroom




2020     |     www.medigraphic.com